Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (21)
Chih-An Shih, Chang-Bih Shie, Wei-Chen Tai, Seng-Kee Chuah, Hsi-Chang Lee & Ping-I Hsu. (2023)
Update on the second-line treatment of
Helicobacter pylori
infection: a narrative review
. Therapeutic Advances in Gastroenterology 16.
Crossref
Crossref
Giuseppe Losurdo, Fulvio Salvatore D’Abramo, Mariapaola Piazzolla, Raffaella Rima, Antonio Continisio, Maria Pricci, Enzo Ierardi & Alfredo Di Leo. (2022) Second-line Therapy for Helicobacter Pylori Eradication: State of the Art. Mini-Reviews in Medicinal Chemistry 22:19, pages 2430-2437.
Crossref
Crossref
Oddmund Nestegard, Kay-Martin Johnsen, Sveinung W. Sørbye, Fred-Arne Halvorsen, Tor Tønnessen, Eyvind J. Paulssen, Kjetil K. Melby, Rasmus Goll & Jon Florholmen. (2020) Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication. PLOS ONE 15:9, pages e0238944.
Crossref
Crossref
Te-Fu Lin & Ping-I Hsu. (2018)
Second-line rescue treatment of
Helicobacter pylori
infection: Where are we now?
. World Journal of Gastroenterology 24:40, pages 4548-4553.
Crossref
Crossref
Soohoon KwonDong Ho LeeJae Bin KangNayoung KimYoung Soo ParkCheol Min ShinHyuk YoonYoon Jin Choi. (2018)
The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in
Helicobacter pylori
Eradication
. The Korean Journal of Gastroenterology 71:4, pages 196.
Crossref
Crossref
Tzung‐Shiun Wu, Ping‐I Hsu, Chao‐Hung Kuo, Huang‐Ming Hu, I‐Chen Wu, Sophie S.W. Wang, Yen‐Hsu Chen, Deng‐Chyang Wu, Wei‐Wen Su & Fu‐Chen Kuo. (2017)
Comparison of 10‐day levofloxacin bismuth‐based quadruple therapy and levofloxacin‐based triple therapy for
Helicobacter pylori
. Journal of Digestive Diseases 18:9, pages 537-542.
Crossref
Crossref
Alicia C. Marin, Olga P. Nyssen, Adrian G. McNicholl & Javier P. Gisbert. (2017) Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. Drugs 77:7, pages 765-776.
Crossref
Crossref
Sung Min Park, Joon Sung Kim, Byung-Wook Kim, Jeong-Seon Ji & Hwang Choi. (2017)
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of
Helicobacter pylori
infection
. Journal of Gastroenterology and Hepatology 32:3, pages 589-594.
Crossref
Crossref
Amin Talebi Bezmin Abadi. (2017) Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 8, pages 123-130.
Crossref
Crossref
J.-M. Liou, C.-C. Chen, Y.-C. Lee, C.-Y. Chang, J.-Y. Wu, M.-J. Bair, J.-T. Lin, M.-J. Chen & M.-S. Wu. (2016)
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 43:4, pages 470-481.
Crossref
Crossref
Priscila Baptistella Yazbek, Ariane Biolcati Trindade, Chung Man Chin & Jean Leandro dos Santos. (2015) Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori. Digestive Diseases and Sciences 60:10, pages 2901-2912.
Crossref
Crossref
Bora Aktaş, Sebahat Başyiğit, Osman Yüksel, Tolga Akkan, Suna Tülin Atbaş, Metin Uzman, Barş Ylmaz, Gülçin Şimşek & Yaşar Nazlgül. (2015) The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies. European Journal of Gastroenterology & Hepatology 27:7, pages 769-775.
Crossref
Crossref
Fernando Marcuz Silva, Elaine Cristina Silveira de Queiroz, Tomás Navarro-Rodriguez, Ricardo Correa Barbuti, Rejane Mattar, Kiyoshi Iriya, Jin Hwa Lee & Jaime Natan Eisig. (2015) Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers. Clinics 70:5, pages 318-321.
Crossref
Crossref
J. P. Gisbert, M. Romano, A. G. Gravina, P. Solís‐Muñoz, F. Bermejo, J. Molina‐Infante, M. Castro‐Fernández, J. Ortuño, A. J. Lucendo, M. Herranz, I. Modolell, F. del Castillo, J. Gómez, J. Barrio, B. Velayos, B. Gómez, J. L. Domínguez, A. Miranda, M. Martorano, A. Algaba, M. Pabón, T. Angueira, L. Fernández‐Salazar, A. Federico, A. C. Marín & A. G. McNicholl. (2015)
Helicobacter pylori
second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments
. Alimentary Pharmacology & Therapeutics 41:8, pages 768-775.
Crossref
Crossref
Javier P. Gisbert, Marco Romano, Javier Molina-Infante, Alfredo J. Lucendo, Enrique Medina, Inés Modolell, Manuel Rodríguez-Tellez, Blas Gomez, Jesús Barrio, Monica Perona, Juan Ortuño, Inés Ariño, Juan Enrique Domínguez-Muñoz, Ángeles Perez-Aisa, Fernando Bermejo, Jose Luis Domínguez, Pedro Almela, Judith Gomez-Camarero, Judith Millastre, Elisa Martin-Noguerol, Antonietta G. Gravina, Marco Martorano, Agnese Miranda, Alessandro Federico, Miguel Fernandez-Bermejo, Teresa Angueira, Luis Ferrer-Barcelo, Nuria Fernández, Alicia C. Marín & Adrián G. McNicholl. (2015) Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments. Digestive and Liver Disease 47:2, pages 108-113.
Crossref
Crossref
Jason Ferreira & Steven F. Moss. (2014) Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection. Current Treatment Options in Gastroenterology 12:4, pages 373-384.
Crossref
Crossref
Jun Heo, Seong Woo Jeon, Jin Tae Jung, Joong Goo Kwon, Eun Young Kim, Dong Wook Lee, Hyang Eun Seo, Chang Yoon Ha, Hyun Jin Kim, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Si Hyung Lee & Byung Ik Jang. (2014) A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication. Digestive and Liver Disease 46:11, pages 980-984.
Crossref
Crossref
Anthony O'Connor, Dino Vaira, Javier P. Gisbert & Colm O'Morain. (2014)
Treatment of
Helicobacter pylori
Infection 2014
. Helicobacter 19:s1, pages 38-45.
Crossref
Crossref
Dong Hyun Oh, Dong Ho Lee, Kyu Keun Kang, Young Soo Park, Cheol Min Shin, Nayoung Kim, Hyuk Yoon, Jin Hyeok Hwang, Sook Hyang Jeoung, Jin Wook Kim, Eun Sun Jang & Hyun Chae Jung. (2014)
The efficacy of hybrid therapy as first-line regimen for
Helicobacter pylori
infection compared with sequential therapy
. Journal of Gastroenterology and Hepatology 29:6, pages 1171-1176.
Crossref
Crossref
Vasilios Papastergiou. (2014)
Treatment of
Helicobacter pylori
infection: Meeting the challenge of antimicrobial resistance
. World Journal of Gastroenterology 20:29, pages 9898.
Crossref
Crossref
Javier P. Gisbert. (2013) Enfermedades relacionadas con la infección por Helicobacter pylori. Gastroenterología y Hepatología 36, pages 39-50.
Crossref
Crossref